Conducting and Reporting a Clinical Research Using Korean Healthcare Claims Database
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
An increasing number of studies are using healthcare claims databases to assess healthcare intervention utilization patterns or outcomes in real-world clinical settings. However, methodological issues affecting study design or data analysis can make conducting and reporting these types of studies difficult. This review presents an overview of the types of information contained in claims data, describes some advantages and limitations of using claims data for research purposes, and outlines steps for utilizing the Korea Health Insurance Review and Assessment and National Health Insurance Service databases. The study also reviews epidemiological approaches utilizing healthcare claims databases (including cross-sectional, case-control, case-crossover, and cohort designs) with respect to protocol development, analysis, and reporting of results, and introduces relevant guidelines and checklists, including the Guidelines for Good Pharmacoepidemiology Practices, the Strengthening the Reporting of Observational Studies in Epidemiology checklist, and the Risk of Bias in Nonrandomized Studies of Interventions tool.
Abstract
An increasing number of studies are using healthcare claims databases to assess healthcare intervention utilization patterns or outcomes in real-world clinical settings. However, methodological issues affecting study design or data analysis can make conducting and reporting these types of studies difficult. This review presents an overview of the types of information contained in claims data, describes some advantages and limitations of using claims data for research purposes, and outlines steps for utilizing the Korea Health Insurance Review and Assessment and National Health Insurance Service databases. The study also reviews epidemiological approaches utilizing healthcare claims databases (including cross-sectional, case-control, case-crossover, and cohort designs) with respect to protocol development, analysis, and reporting of results, and introduces relevant guidelines and checklists, including the Guidelines for Good Pharmacoepidemiology Practices, the Strengthening the Reporting of Observational Studies in Epidemiology checklist, and the Risk of Bias in Nonrandomized Studies of Interventions tool.
참고문헌 (33)
- Singh G, "Real world big data for clinical research and drug development", Drug Discov Today, 23, pp.652~660 (2018)
- "21st Century Cures Act. H.R.34, 114th Congress" (2016)[URL]
- Chun CB, "Republic of Korea : health system review", Health Syst Transit, 11, pp.1~184 (2009)
- Data governance arrangements for real-world evidence: South Korea, "Lee EK", Office of Health Economics, ~ (2017)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Ryu DR, "Introduction to the medical research using National Health Insurance Claims Database", Ewha Med J, 40, pp.66~70 (2017)
- "Healthcare system in Korea: health security system"[URL]
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples", Epidemiol Health, 36, pp.e2014008~ (2014)
- 김록영, "입원 환자 표본 개발에 관한 연구: 국민건강보험 청구자료를 중심으로", 보건행정학회지, 23(2), pp.152~161 (2013), 한국보건행정학회
- Seong SC, "Cohort profile : the National Health Insurance Service-National Health Screening Cohort(NHIS-HEALS)in Korea", BMJ Open, 7, pp.e016640~ (2017)
- Kim YI, "Cohort profile : National health insurance service-senior(NHIS-senior)cohort in Korea", BMJ Open, 9, pp.e024344~ (2019)
- 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
- Chung H, "Clinical research from a Health Insurance Database : practice and perspective", Korean J Med, 94, pp.463~470 (2019)
- Lew WJ, "An internetbased surveillance system for tuberculosis in Korea", Int J Tuberc Lung Dis, 10, pp.1241~1247 (2006)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- Cho HY, "Immunization decision-making in the Republic of Korea : the structure and functioning of the Korea Advisory Committee on Immunization Practices", Vaccine, 28(Suppl 1), pp.A91~A95 (2010)
- Schneeweiss S, "A review of uses of health care utilization databases for epidemiologic research on therapeutics", J Clin Epidemiol, 58, pp.323~337 (2005)
- Grimes DA, "An overview of clinical research : the lay of the land", Lancet, 359, pp.57~61 (2002)
- Jung SY, "Utilisation of medications among elderly patients in intensive care units : a cross-sectional study using a nationwide claims database", BMJ Open, 9, pp.e026605~ (2019)
- Jung SY, "Oral bisphosphonates and upper gastrointestinal cancer risks in Asians with osteoporosis : a nested case-control study using national retrospective cohort sample data from Korea", PLoS One, 11, pp.e0150531~ (2016)
- Park S, "Effect of late-life weight change on dementia incidence : a 10-year cohort study using claim data in Korea", BMJ Open, 9, pp.e021739~ (2019)
- Grimes DA, "Bias and causal associations in observational research", Lancet, 359, pp.248~252 (2002)
- Yang BR, "Prescription of zolpidem and the risk of fatal motor vehicle collisions : a population-based, case-crossover study from South Korea", CNS Drugs, 32, pp.593~600 (2018)
- Didham RC, "Suicide and selfharm following prescription of SSRIs and other antidepressants : confounding by indication", Br J Clin Pharmacol, 60, pp.519~525 (2005)
- Shrank WH, "Healthy user and related biases in observational studies of preventive interventions : a primer for physicians", J Gen Intern Med, 26, pp.546~550 (2011)
- Prada-Ramallal G, "Bias in pharmacoepidemiologic studies using secondary health care databases : a scoping review", BMC Med Res Methodol, 19, pp.53~ (2019)
- Walraven CV, "A comparison of methods to correct for misclassification bias from administrative database diagnostic codes", Int J Epidemiol, 47, pp.605~616 (2018)
- Studying on diagnosis accuracy for health insurance claims data in Korea, "Park BJ", Seoul National University, ~ (2003)
- Strom BL, "Pharmacoepidemiology", pp.158~162 (2012), John Wiley & Sons
- Public Policy Committee, "International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP)", Pharmacoepidemiol Drug Saf, 25, pp.2~10 (2016)
- Von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE)statement : guidelines for reporting observational studies", Ann Intern Med, 147, pp.573~577 (2007)
- Sterne JA, "ROBINS-I : a tool for assessing risk of bias in non-randomised studies of interventions", BMJ, 355, pp.i4919~ (2016)